Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Mylan Inc. reports that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the US commercialization, marketing, and intellectual property rights relating to Arixtra (fondaparinux sodium) injection and the authorized...

Cipla, a global pharmaceutical company, has formed a commercial collaboration with S&D Pharma in the Czech Republic and Slovakia. This collaboration will enable Cipla to focus on its core therapy areas while S&D Pharma will be the key...

Actavis plc reports that the US Food and Drug Administration (FDA) has accepted for filing Actavis' application for ceftazidime-avibactam, an investigational antibiotic being developed to treat serious Gram-negative bacterial infections....

Johnson & Johnson (J&J) will fast-track the development of a new combination vaccine regimen against Ebola and broadly collaborate with its partners in global health to address the current Ebola outbreak in West Africa. The accelerated...

Merck & Co., reports that the US Food and Drug Administration (FDA) has designated relebactam, the company's investigational beta-lactamase inhibitor, as a Qualified Infectious Disease Product (QIDP) with designated Fast Track status....

Teva Pharmaceutical Industries Ltd. has launched the generic equivalent to Baraclude (entecavir) tablets, 0.5 mg and 1mg, in the United States. Teva was first to file, making the product eligible for 180 days of marketing exclusivity, according to...